Al-Hassany, Linda
Rubio-Beltrán, Eloisa
Labastida-Ramirez, Alejandro
Garrelds, Ingrid M.
Danser, A. H. Jan
Roks, Anton J. M.
MaassenVanDenBrink, Antoinette
Funding for this research was provided by:
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Vici Grant (09150181910040))
Article History
Received: 21 March 2026
Accepted: 25 June 2026
First Online: 3 July 2026
Declarations
:
: The study was planned and carried out in accordance with the Principles of Laboratory Animal Care and with guidelines approved by an independent Animal Ethics Committee, consulted at the Erasmus MC, as well as the ARRIVE guidelines.
: Not applicable.
: Not applicable.
: Linda Al-Hassany, Eloisa Rubio-Beltrán, Alejandro Labastida-Ramirez, Anton JM Roks, Ingrid M Garrelds, and A.H. Jan Danser declare no conflict of interest with respect to the research, authorship, and/or publication of this article. Antoinette MaassenVanDenBrink received research grants and/or consultation fees from AbbVie, Amgen/Novartis, Eli Lilly, Lundbeck, Manistee, Pfizer, Satsuma, Teva, and Tonix.